Drug Shortage Report for ETOPOSIDE INJECTION
| Report ID | 174607 |
| Drug Identification Number | 02080036 |
| Brand name | ETOPOSIDE INJECTION |
| Common or Proper name | ETOPOSIDE INJECTION 20MG/ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ETOPOSIDE |
| Strength(s) | 20MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 |
| ATC code | L01CB |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-14 |
| Estimated end date | 2023-02-10 |
| Actual end date | 2023-02-07 |
| Shortage status | Resolved |
| Updated date | 2023-02-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-02-09 | French | Compare |
| v6 | 2023-02-09 | English | Compare |
| v5 | 2022-12-01 | French | Compare |
| v4 | 2022-12-01 | English | Compare |
| v3 | 2022-11-15 | English | Compare |
| v2 | 2022-11-14 | French | Compare |
| v1 | 2022-11-14 | English | Compare |
Showing 1 to 7 of 7